CIK 0001691082 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
LB PHARMACEUTICALS INC
Sign in to watch- Ticker
- LBRX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 917-450-6581
- Business address
- 575 MADISON AVENUE, NEW YORK, NY, 10022
- Former names
- LB PHARMACEUTICALS INC.
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 424B3 Offering Prospectus
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- ARS Other Annual Report to Security Holders
- DEFA14A Proxy Proxy Materials
- DEF 14A Proxy Proxy Statement
- EFFECT Other Notice of Effectiveness
- 424B3 Offering Prospectus
- CORRESP Other Correspondence Between Filers and SEC Staff
- UPLOAD Other SEC-generated Letter
- S-1 Offering Registration Statement
- S-8 Other Securities Offered to Employees in Benefit Plans
- 10-K Report Annual Report
- 8-K Event Results of operations
- 8-K Event Executive or director change
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 8-K Event Executive or director change · Regulation FD disclosure
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
Page 3 of 8 · 143 filings